References
- 1. Perico N, Cattaneo D, Sayegh MH, Remuzzi G. Delayed graft function in kidney transplantation. Lancet, 2004, 364, No. 9447, 1814-1827.
- 2. Ojo AO, Wolfe RA, Held PJ et al. Delayed graft function: risk factors and implications for renal allograft survival. Transplantation, 1997, 63, No. 7, 968-974.
- 3. Koning OHJ, van Bockel JH, van der Woude FJ et al. Risk factors for delayed graft function in University of Wisconsin solution preserved kidneys from multiorgan donors. Transplantation Proceedings, 1995, 27, No.1, 752-753.
- 4. Sellers MT, Gallichio MH, Hudson SL et al. Improved outcomes in cadaveric renal allografts with pulsatile preservation. Clinical Transplantation, 2000, 14, No. 6, 543-549.
- 5. Gjertson DW. Impact of delayed graft function and acute rejection on kidney graft survival. Clinical Transplants, 2000, 467-480.
- 6. Yarlagadda SG, Coca SG, Garg AX et al. Marked variation in the definition and diagnosis of delayed graft function: a systematic review. Nephrology Dialysis Transplantation, 2008, 23, No. 9, 2995-3003.
- 7. Boom H, Mallat MJK, De Fijter JW et al. Delayed graft function influences renal function, but not survival. Kidney International, 2000, 58, No. 2, 859-866.
- 8. Giral-Classe M, Hourmant M, Cantarovich D et al. Delayed graft function of more than six days strongly decreases long-term survival of transplanted kidneys. Kidney International, 1998, 54, No. 3, 972-978.
- 9. Lu CY, Penfield JG, Kielar ML et al. Hypothesis: is renal allograft rejection initiated by the response to injury sustained during the transplant process. Kidney International, 1999, 55, No. 6, 2157-2168.
- 10. Shoskes DA, Cecka JM. Deleterious effects of delayed graft function in cadaveric renal transplant recipients independent of acute rejection. Transplantation, 1998, 66, No. 12, 1697-1701.
- 11. Troppmann C, Gillingham KJ, Gruessner RWG et al. Delayed graft function in the absence of rejection has no long-term impact. A study of cadaver kidney recipients with good function at 1 year after transplantation. Transplantation, 1996, 61, No. 9, 1331-1337.
- 12. Mehta RL, Chertow GM. Acute renal failure definitions and classification: time for change? Journal of the American Society of Nephrology, 2003, 14, No. 8, 2178-2187.
- 13. Bolignano D, Coppolino G, Lacquaniti A, Buemi M. From kidney to cardiovascular diseases: NGAL as a biomarker beyond the confines of nephrology. European Journal of Clinical Investigation, 2010, 40, No. 3, 273-276.
- 14. Mori K, Lee HT, Rapoport D et al. Endocytic delivery of lipocalin-siderophore-iron complex rescues the kidney from ischemia-reperfusion injury. Journal of Clinical Investigation, 2005, 115, No. 3, 610-621.
- 15. Mishra J, Qing MA, Prada A et al. Identification of neutrophil gelatinase-associated lipocalin as a novel early urinary bio-marker for ischemic renal injury. Journal of the American Society of Nephrology, 2003, 14, No. 10, 2534-2543.
- 16. Parikh CR, Jani A, Mishra J et al. Urine NGAL and IL-18 are predictive biomarkers for delayed graft function following kidney transplantation. American Journal of Transplantation, 2006, 6, No. 7, 1639-1645.
- 17. Mishra J, Ma Q, Kelly C et al. Kidney NGAL is a novel early marker of acute injury following transplantation. Pediatric Nephrology, 2006, 21, No. 6, 856-863.
- 18. Malyszko J, Malyszko JS, Mysliwiec M. Serum neutrophil gelatinase-associated lipocalin correlates with kidney function in renal allograft recipients. Clinical Transplantation, 2009, 23, No. 5, 681-686.
- 19. Malyszko J, Malyszko JS, Bachorzewska-Gajewska H et al. Neutrophil gelatinase-associated lipocalin is a new and sensitive marker of kidney function in chronic kidney disease patients and renal allograft recipients. Transplantation Proceedings, 2009, 41, No. 1, 158-161.
- 20. Lebkowska U, Malyszko J, Lebkowska A et al. Neutrophil gelatinase-associated lipocalin and cystatin C could predict renal outcome in patients undergoing kidney allograft transplantation: a prospective study. Transplantation Proceedings, 2009, 41, No. 1, 154-157.
- 21. Kusaka M, Kuroyanagi Y, Mori T et al. Serum neutrophil gelatinase-associated lipocalin as a predictor of organ recovery from delayed graft function after kidney transplantation from donors after cardiac death. Cell Transplantation, 2008, 17, No. 1-2, 129-134.
- 22. Hollmen ME, Kyllönen LE, Inkinen KA et al. Urine neutrophil gelatinase-associated lipocalin is a marker of graft recovery after kidney transplantation. Kidney International, 2011, 79, No. 1, 89-98.
- 23. Hollmen ME, Kyllönen LE, Inkinen KA et al. Deceased donor neutrophil gelatinase-associated lipocalin and delayed graft function after kidney transplantation: a prospective study. Critical Care, 2011, 15, No. 3, article R121.
- 24. Hall IE, Yarlagadda SG, Coca SG et al. IL-18 and urinary NGAL predict dialysis and graft recovery after kidney transplantation. Journal of the American Society of Nephrology, 2010, 21, No. 1, 189-197.
- 25. Bataille A, Abbas S, Semoun O et al. Plasma neutrophil gelatinase-associated lipocalin in kidney transplantation and early renal function prediction. Transplantation, 2011, 92, No. 9, 1024-1030.
- 26. Magnusson NE, Hornum M, Jorgensen KA et al. Plasma neutrophil gelatinase associated lipocalin (NGAL) is associated with kidney function in uraemic patients before and after kidney transplantation. BMC Nephrology, 2012, 13, article 8.
- 27. Kusaka M, Iwamatsu F, Kuroyanagi Y et al. Serum neutrophil gelatinase associated lipocalin during the early postoperative period predicts the recovery of graft function after kidney transplantation from donors after cardiac death. Journal of Urology, 2012, 187, No. 6, 2261-2267.
- 28. Premaratne E, MacIsaac RJ, Finch S et al. Serial measurements of cystatin c are more accurate than creatinine-based methods in detecting declining renal function in type 1 diabetes. Diabetes Care, 2008, 31, No. 5, 971-973.
- 29. Stevens LA, Coresh J, Schmid CH et al. Estimating GFR using serum cystatin C alone and in Combination with serum creati-nine: a pooled analysis of 3,418 individuals with CKD. American Journal of Kidney Diseases, 2008, 51, No. 3, 395-406.
- 30. Perkins BA, Nelson RG, Ostrander BEP et al. Detection of renal function decline in patients with diabetes and normal or elevated GFR by serial measurements of serum cystatin C concentration: results of a 4-year follow-up study. Journal of the American Society of Nephrology, 2005, 16, No. 5, 1404-1412.
- 31. Laterza OF, Price CP, Scott MG. Cystatin C: an improved estimator of glomerular filtration rate? Clinical Chemistry, 2002, 48, No. 5, 699-707.
- 32. Cowland JB, Sørensen OE, Sehested M, Borregaard N. Neutrophil gelatinase-associated lipocalin is up-regulated in human epithelial cells by IL-1 beta, but not by TNF-α. Journal of Immunology, 2003, 171, No. 12, 6630-6639.
- 33. Devarajan P. Neutrophil gelatinase-associated lipocalin: a promising biomarker for human acute kidney injury. Biomarkers in Medicine, 2010, 4, No. 2, 265-280.
- 34. Jung K, Diego J, Scholz D et al. Urinary enzyme excretion by renal-transplant recipients in relation to interval after transplantation. Clinical Chemistry 1982;28(2):1762-1764.
- 35. Marchewka Z, Kuzniar J, Dlugosz A. Enzymatic markers of cyclosporine nephrotoxicity in patients after renal transplantation. Int Urol Nephrol 1999;31:727-34.
- 36. Skálová S. the diagnostic role of urinary n-acetyl-β β-dglucosaminidase (NAG) activity in the detection of renal tubular impairment. ACTA MEDICA (Hradec Králové) 2005;48(2):75-80.
- 37. Burne-Taney MJ, Yokota N, Rabb H. Persistent renal and extrarenal immune changes after severe, ischemic injury. Kidney Int 67: 1002-1009. Cecka JM 2002, The UNOS Renal Transplant Registry. Clin Transpl, 2005, 1-20.
- 38. Cosio FG, Grande JP, Larson TS et al. Kidney allograft fibrosis and atrophy early after living donor transplantation. Am J Transplant, 2005, 5: 1130-1136.
- 39. Doi K, Katagiri D, Negishi K et al. Mild elevation of urinary biomarkers in prerenal acute kidney injury. Kidney Int, 2012, 82: 1114-11120.
- 40. Domański L, Kłoda K, Pawlik A et al Correlation between ICAM1 and VCAM1 gene polymorphisms and histopathological changes in kidney allograft biopsies. Arch Med Sci, 2013, 9: 276-282.